Investigational New Drug Application for ABC294640 in Advanced Solid Tumors Approved

Apogee is pleased to announce approval from the Food and Drug Administration  for the Investigational New Drug Application for ABC294640 for advanced solid tumors and advanced pancreatic cancer .  Apogee anticipates the start of the clinical trial at the beginning of 2011.

Powered by THE BRAVO GROUP & ARCHODA: CREATE SOMETHING UNIQUE